About Emmes
Emmes news and updates
The Emmes Corporation acquired orphan reach Ltd on May 1st 21'.
Emmes acquired the UK-based Orphan Reach in May.
Jan 1, 2021 | financialexpress.comThe Emmes Corporation acquired Casimir, LLC. on Mar 10th 22'.
Emmes (the “Company”), a global, full-service Clinical Research Organization (CRO) dedicated to supporting the advancement of public health and biopharmaceutical innovation and a portfolio company of Behrman Capital, today announced that it has acquired Casimir.
Jan 1, 2022 | globalbankingandfinance.comThe Emmes Corporation acquires Casmir
Emmes, which is backed by Behrman Capital, has acquired Plymouth, Massachusetts-based Casmir, a clinical research organization.
Jan 1, 2022 | pehub.comThe Emmes Corporation launches third generation version of Advantage eClinical
Emmes has announced the launch its third generation version of Advantage eClinical.
Jan 1, 2022 | appliedclinicaltrialsonline.comNew Mountain Capital acquires The Emmes Corporation for $800M
New Mountain Capital agreed to buy The Emmes Corporation, a Rockville, Marlyand-based government-centric contract research organization (CRO), from Behrman Capital for more than US$ 800 million, according to various media sources.
Jan 1, 2022 | swfinstitute.orgThe Emmes Corporation acquired Clinical Edge Pty on Sep 28th 22'.
Emmes announced that it has acquired Clinical Edge.
Sep 27, 2022 | appliedclinicaltrialsonline.comThe Emmes Corporation partners with National Institutes of Health
Mendizabal explained that Emmes has partnered with the National Institutes of Health and with biopharma companies to evaluate promising therapeutic approaches in multi-institutional clinical trials to improve the outcomes of blood and marrow transplantation and other cellular therapies for patients facing life-threatening blood disorders.
Dec 8, 2022 | prnewswire.comThe Emmes Corporation launches dedicated center to enhance Emmes
Emmes, a global, full-service Clinical Research Organization (CRO) dedicated to supporting the advancement of public health and biopharmaceutical innovation, has created a dedicated center to enhance Emmes’ legacy and depth in cell and gene therapy research.
Dec 8, 2022 | contractpharma.comThe Emmes Corporation hires Ching Tian as chief innovation officer
Emmes, a global, full-service CRO has appointed Ching Tian as chief innovation officer.
Dec 14, 2022 | contractpharma.comThe Emmes Corporation hires Wendy Buckland as chief operating officer
Emmes, a global, full-service CRO, has appointed Wendy Buckland as chief operating officer, leading global operations.
Dec 15, 2022 | contractpharma.comThe Emmes Corporation partners with NIH StrokeNet
Mendizabal explained that Emmes has partnered with the National Institutes of Health and with biopharma companies to evaluate promising therapeutic approaches in multi-institutional clinical trials to improve the outcomes of blood and marrow transplantation and other cellular therapies for patients facing life-threatening blood disorders.
Dec 7, 2022 | biohealthinnovation.org